Skip to main content
. Author manuscript; available in PMC: 2016 Oct 27.
Published in final edited form as: Anesthesiology. 2016 Jun;124(6):1265–1276. doi: 10.1097/ALN.0000000000001108

Table 4.

Agreement between Survey and Manual Chart Review (N = 750)

Complication Frequency
Agreement
Survey Negative; Chart Review Negative Survey Negative; Chart Review Positive Survey Positive; Chart Review Negative Survey Positive; Chart Review Positive Positive Agreement (%) Negative Agreement (%) Kappa (95% CI)
Myocardial infarction 743 0 7 0 0 > 99
Cardiac arrest 745 0 5 0 0 > 99
Congestive heart failure 726 1 22 1 8 98 0.08 (−0.07 to 0.22)
Arrhythmia 651 13 56 30 47 95 0.42 (0.31 to 0.53)
Angina 740 2 7 1 18 99 0.18 (−0.13 to 0.48)
Stroke 739 0 7 4 53 > 99 0.53 (0.22 to 0.84)
Deep venous thrombosis 728 2 15 5 37 99 0.36 (0.13 to 0.59)
Pulmonary embolism 742 0 5 3 55 > 99 0.54 (0.19 to 0.90)
Wound infection 706 8 35 1 4 97 0.02 (−0.06 to 0.11)
Respiratory arrest 743 0 7 0 0 100
Respiratory failure 728 0 20 2 17 99 0.16 (−0.04 to 0.36)
Pneumonia 729 0 17 4 32 99 0.31 (0.08 to 0.55)
Kidney failure requiring dialysis 734 0 14 2 22 99 0.22 (−0.03 to 0.47)
Nerve injury 706 6 32 6 24 97 0.22 (0.06 to 0.38)
Gastrointestinal bleed 739 1 9 1 17 99 0.16 (−0.12 to 0.45)
Peptic ulcer 742 1 7 0 0 99 0.00 (−0.01 to 0.00)
Severe pain > 1 day 464 98 110 78 43 82 0.25 (0.17 to 0.32)
Severe nausea/vomiting > 1 day 550 137 28 35 30 87 0.20 (0.12 to 0.28)

Note that these 750 patients are a subset of the 1,578 patients shown in table 3. Kappa is undefined if either the survey or the chart review identifies zero cases of a particular complication.